Linda Schwimmer, president and CEO of the New Jersey Health Care Quality Institute, discusses the impact of the group’s report, Medicaid 2.0, which outlined how the state can bring healthcare transformation principles to a program that consumes a fifth of the state budget. New Jersey elected a new governor in November, and the blueprint was widely seen a policy recommendation for the next administration.
Linda Schwimmer, president and CEO of the New Jersey Health Care Quality Institute (NJHCQI), discusses the impact of the group’s report, Medicaid 2.0, which outlined how the state can bring healthcare transformation principles to a program that consumes a fifth of the state budget. New Jersey elects a new governor in November, and the blueprint was widely seen a policy recommendation for the next administration.
Transcript
A key recommendation of NJHCQI's Medicaid 2.0 report was for the next governor to create an Office of Health Care Transformation. Are you optimistic this will happen?
I am optimistic about the Office of Health Care Transformation. We’ve seen this model work in other states. In New Jersey, what we’ve seen is healthcare is spread across 7 different departments often leading to siloed decision-making, and sometimes competitive actions between departments—and a lack of a vision for where healthcare needs to go, and where our healthcare dollars need to go as a state. When we’ve spoken to candidates [before the election on November 7], as well as leaders across the healthcare industry, we’ve had broad consensus support for this type of action. I think all of the healthcare challenges we have, it would be the smartest thing our new governor could do.
Do you think Medicaid transformation will happen in New Jersey?
We have transformed our Medicaid system to some extent over the last 5 years, just through the expansion of the Medicaid population and a lot of the work that’s been done through the current waiver. But we still have a lot more to do. The Medicaid 2.0 process really convened all of the stakeholders to have discussions about where our Medicaid system needs to go, now and into the future. Given that 20% of our population receives its healthcare through Medicaid, and over 40% of our births are paid for by Medicaid, and a high percentage of seniors receive care through Medicaid, we’re really talking about care for a lot of people and some of our neediest and most vulnerable residents in New Jersey, there’s a lot we can do. The blueprint points us in 24 different directions with its recommendations.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More